Mallinckrodt
Mallinckrodt Pharmaceuticals is a global leader in specialty pharmaceuticals, committed to improving lives through innovative solutions. With over 150 years of heritage, the company focuses on severe and critical conditions, leveraging core strengths in development, formulation, regulatory expertise, manufacturing, and logistics. It values quality, integrity, and service, and actively engages in strategic acquisitions, partnerships, and sustainability initiatives to deliver impactful medical solutions worldwide.
Industries
Nr. of Employees
Very Large (1000+)
Mallinckrodt
Blanchardstown, Dublin, Ireland, Europe
Patents
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
US-9562014-B2
View Details
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
US-9562014-B2
View DetailsProducts
Specialty pharmaceutical portfolio (therapeutic areas)
Commercial and development-stage products focused on autoimmune and rare diseases, and specialty areas including neurology, rheumatology, nephrology, pulmonology and ophthalmology.
Neonatal respiratory and critical care therapies
Products and development programs targeting neonatal respiratory critical care and other critical care indications.
Analgesics and related pain management products
Commercial analgesic products and related formulations serving pain management needs.
Gaseous delivery devices for medical treatment
Medical devices for gaseous delivery used in specified clinical treatments.
Development-stage metabolic/organ support therapies
Examples of development-stage assets (e.g., metabolic support compounds) acquired to expand pipeline; referenced as pipeline programs on archived pipeline pages.
Specialty pharmaceutical portfolio (therapeutic areas)
Commercial and development-stage products focused on autoimmune and rare diseases, and specialty areas including neurology, rheumatology, nephrology, pulmonology and ophthalmology.
Neonatal respiratory and critical care therapies
Products and development programs targeting neonatal respiratory critical care and other critical care indications.
Analgesics and related pain management products
Commercial analgesic products and related formulations serving pain management needs.
Gaseous delivery devices for medical treatment
Medical devices for gaseous delivery used in specified clinical treatments.
Development-stage metabolic/organ support therapies
Examples of development-stage assets (e.g., metabolic support compounds) acquired to expand pipeline; referenced as pipeline programs on archived pipeline pages.
Services
Collaborative development partnerships, in-licensing, out-licensing, targeted acquisitions, and dedicated alliance management for clinical-stage assets (Phase II+).
Internal and external manufacturing oversight, supply chain distribution, device engineering support, technical services and product support for specialty pharmaceutical products.
Post-market safety monitoring, pharmacovigilance programs and global medical information services to support marketed products and clinical development.
Administration of investigator-initiated research, medical writing and education grants, and support for externally sponsored clinical research.
Supplier engagement and due-diligence processes to identify country of origin of raw materials, conflict minerals reporting and supplier code-of-conduct enforcement.
Collaborative development partnerships, in-licensing, out-licensing, targeted acquisitions, and dedicated alliance management for clinical-stage assets (Phase II+).
Internal and external manufacturing oversight, supply chain distribution, device engineering support, technical services and product support for specialty pharmaceutical products.
Post-market safety monitoring, pharmacovigilance programs and global medical information services to support marketed products and clinical development.
Administration of investigator-initiated research, medical writing and education grants, and support for externally sponsored clinical research.
Supplier engagement and due-diligence processes to identify country of origin of raw materials, conflict minerals reporting and supplier code-of-conduct enforcement.
Expertise Areas
- Formulation development and specialized chemistry
- Regulatory compliance and submissions
- Pharmaceutical manufacturing and supply chain management
- Biologics operations and scale-up
Key Technologies
- Pharmaceutical formulation chemistry
- Biologics (monoclonal antibody) manufacturing
- Technology transfer and manufacturing scale-up
- Medical device engineering
News & Updates
Learn how we’re advancing sustainability for a brighter tomorrow.
Our values and culture are the driving force behind everything we do.
Our goal is to price our products responsibly while providing the best healthcare.
Building on our heritage and capabilities to bring medical solutions to the marketplace.
Announcement of leadership team for the merged company.
Data presentation at the International Congress on Systemic Lupus Erythematosus.
Learn how we’re advancing sustainability for a brighter tomorrow.
Our values and culture are the driving force behind everything we do.
Our goal is to price our products responsibly while providing the best healthcare.
Building on our heritage and capabilities to bring medical solutions to the marketplace.
Announcement of leadership team for the merged company.
Data presentation at the International Congress on Systemic Lupus Erythematosus.